Press Releases

Visit booth 106 to learn how Covalon is leading the charge with compassion driven innovation through gentler infection prevention solutions. MISSISSAUGA, ON, March 20, 2023 /CNW/ - Covalon...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF) an advanced medical technologies company, today announced the results of the matters voted upon at its Fiscal 2022...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF) an advanced medical technologies company, today is delighted to announce that Martin Goldfarb has joined its Board...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, has announced that the annual and special meeting of shareholders of...

Revenue growth of 25%, significant margin improvement and strong balance sheet MISSISSAUGA, ON, Feb. 23, 2023 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX:...

Visit booth 100 to learn how Covalon's products are uniquely designed to help prevent CLABSIs and SSIs while providing more gentle, compassionate experiences for neonates and young children....

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q1 Fiscal 2023 financial results on Thursday, February...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2022 fourth quarter and year end results for...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q4 and year end Fiscal 2022 financial results on...

A two-year study with the aim of preventing sternal wound infections highlights SurgiClear as a key component of the infection prevention bundle used to significantly reduce infection rates...

Amongst a climbing Central Line Associated Blood Stream Infection ("CLABSI") rate across the United States, Covalon is releasing new digital resources focused on the role of technology to...

Evidence on Covalon's New ColActive Plus Powder presented at the Symposium on Advanced Wound Care MISSISSAUGA, ON, Nov. 1, 2022 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon")...

Visit Covalon at booth 1557 from October 13 to October 15, 2022 at the Pennsylvania Convention Center MISSISSAUGA, ON, Oct. 11, 2022 /CNW/ - Covalon Technologies Ltd. (the "Company" or "Covalon")...

Visit Covalon to learn how new compassionate care technology is protecting patients from infections, while strengthening patient-centered care. MISSISSAUGA, ON, Sept. 28, 2022 /CNW/ - Covalon...

Book an appointment with us and visit booth 607 at the Minneapolis Convention Center from September 30 to October 2 to learn more MISSISSAUGA, ON, Sept. 26, 2022 /CNW/ - Covalon Technologies Ltd....

Advanced post-operative dressing is now used to prevent post-operative infections in patients with congenital heart conditions from birth through adulthood. MISSISSAUGA, ON, Sept. 20, 2022 /CNW/ -...

Ensuring that health professionals caring for the youngest patients have access to advanced wound care and infection prevention solutions Visit Covalon at booth 307 at the 46th Annual APHON...

Covalon's compassionate care technology is quickly becoming a standard of care in more than 17% of pediatric hospitals in the US. MISSISSAUGA, ON, Sept. 8, 2022 /CNW/ - Covalon Technologies Ltd....

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF) an advanced medical technologies company, today is pleased to announce that the Company's Board of Directors has...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal 2022 results. Brian Pedlar,...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, will release its Q3 Fiscal 2022 financial results on Monday, August...

Covalon Technologies Ltd. (TSXV: COV) (OTCQX: CVALF) (the "Company" or "Covalon"), an advanced medical technologies company, today announced that it has entered into an automatic share purchase...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTCQX: CVALF), an advanced medical technologies company, today announced its second quarter fiscal 2022 results. Brian Pedlar,...

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV) (OTC: CVALF), an advanced medical technologies company, will release its Q2 Fiscal 2022 financial results on Monday May 30th,...

Covalon Technologies Ltd. (TSXV: COV) (OTCQX: CVALF) (the "Company" or "Covalon"), an advanced medical technologies company, today announced that it has filed its intention to make a normal course...